Pfizer Is Named World’s Biggest R&D Investor, Company Announces Personnel Changes

October 5, 2007--The 2007 EU Industrial R&D Investment Scoreboard names Pfizer as the world’s biggest investor in R&D. Also according to the report, pharmaceuticals & biotechnology has become the top R&D investing sector, with Merck, AstraZeneca, Roche, Johnson & Johnson, and GlaxoSmithKline showing a strong increase in R&D investment. The press release can be downloaded from the Industrial Research & Innovation Web site of the European Commission’s Directorate-General Joint Research Centre.

In other news, Pfizer named Dr. Martin Mackay as President of Pfizer Global Research and Development (PGRD); launched an independent, stand-alone biotherapeutics and bioinnovation center under the direction of scientist and entrepreneur Dr. Corey Goodman; and named Dr. Briggs Morrison, who held senior research and development positions at Merck, as its new Head of Clinical Development for the PGRD pipeline. See the Pfizer press release from 10/4.